![](/img/cover-not-exists.png)
KRAS mutation and primary tumor location do not affect efficacy of bevacizumab-containing chemotherapy in stagae IV colorectal cancer patients
Sun, De-cong, Shi, Yan, Wang, Yan-rong, Lv, Yao, Yan, Huan, Mao, Hui, Wang, Zhi-kuan, Wu, Zhi-yong, Shi, Wei-wei, Dai, Guang-haiVolume:
7
Language:
english
Journal:
Scientific Reports
DOI:
10.1038/s41598-017-14669-2
Date:
December, 2017
File:
PDF, 1.58 MB
english, 2017